Express Pharma

JUNE 5, 2025

The initiative builds upon the foundation set by the first edition of the report, which was released in 2022. That report has since been used as a reference document across various platforms.

Documentation

Beckers Hospital Review

JULY 23, 2025

From problem to progress: easing documentation burden One of the clearest examples of this mindset is how we approached provider burnout tied to EHR documentation. The results were clear: providers overwhelmingly preferred the AI scribe, and we saw meaningful reductions in documentation time and provider burnout.

Documentation

Pharmacy Times

JUNE 9, 2025

Study Overview Researchers conducted a retrospective chart review of 80 patients aged 12 or older within Intermountain Health who were diagnosed with asthma between December 2022 and December 2023. 1 The study also observed that 65% of patients had a documented visit with an asthma specialist during the follow-up period.

Pharmacy Technician

Pharmacy Times

JULY 2, 2025

They can collect documentation on prior preventive therapies, baseline MMDs, and follow-up outcomes to support prior authorization, including site-of-care arrangements. of participants discontinued due to adverse effects.

Pharmacy Technician

Pharmacy Times

JULY 17, 2025

Reviewing Medication Adherence According to the WeAllCount Census for 2022 to 2023, 6 homelessness in San Diego increased by 22% (from 8427 to 10,264 individuals). After a thorough chart review of each patient’s profile, 278 patients met the inclusion criteria, and 47 were excluded for not having any documented psychiatric home medications.

HIV Treatment and Prevention Agents

Beckers Hospital Review

AUGUST 12, 2025

Drugmaker Sun Pharma pledged sweeping reforms after years of persistent safety violations at its flagship manufacturing plant in Halol, India, but failed to follow through, according to FDA documents obtained by ProPublica. An import ban was imposed in late 2022; however, more than a dozen drugs were exempted and could still reach U.S.

Documentation

Pharmaceutical Technology

JULY 11, 2025

The rising volume of clinical trials increases demand and competition for patients The number of oncology assets in the clinical development pipeline has increased by 13% annually over five years (2018-2022) 1. To learn more about the solutions provided by Paradigm Health, download the document below.

Drug Pricing

STAT

APRIL 9, 2025

government paper documenting an increase in maternal mortality from 2018 to 2022 does not hedge in its conclusion, calling the issue “an urgent public health priority.” ” That it was published amid massive job and funding cuts at federal health agencies charged with reducing these deaths has not escaped notice.

Documentation

Pharmaceutical Commerce

AUGUST 12, 2025

Criminal networks exploit forged documentation , fake packaging, and corrupt distributors to infiltrate regulated supply chains with dangerous products. As is typical in such cases, the buyers were deceived by counterfeit pedigree documents and false assurances from the sellers. August 2, 2022. September 28, 2022.

Packaging

Putting Patients First Blog

JUNE 16, 2025

Developers should be required to: Conduct inclusive usability testing with older adults, people with disabilities, caregivers, and individuals with limited English proficiency; Share documentation of feedback collection and integration; and Comply with Section 508 and WCAG 2.1 Incentivizing the use of HL7 FHIR, OAuth 2.0,

Documentation

Viseven

JUNE 4, 2025

And patients gladly take the opportunity to access their online medical records — 54% reviewed their records at least three times during 2022 , compared to 38% in 2020. Medical histories, test results, and treatment plans are now shared seamlessly, ensuring everyone is on the same page.

Communication

Pharmaceutical Technology

JULY 16, 2025

Robert Barrie July 16, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Shares in London-listed GSK closed 1.19% down following the document release. Experts also identified poor tolerability of regimens and resulting uncertainty regarding proposed dose, as per a briefing document published on 15 July.

Documentation

The Thyroid Pharmacist

AUGUST 1, 2025

One 2022 study even suggests that a third of women who deliver via C-section may experience delayed lactogenesis II. [40] Updated 2022 Jul 25]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. 2022 Apr 28;14(9):1846. 2022 Apr 28;14(9):1846. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz.

Health and Personal Care Stores

Beckers Hospital Review

JULY 17, 2025

To meet this challenge, Infirmary Health redesigned its clinical documentation integrity process without adding staff. This innovative approach has dramatically reduced the documentation burden on our physicians, enabling them to spend more meaningful time focused on patient interactions rather than on manual note-taking.

Insurance Coverage and Processing

Pharmaceutical Technology

JULY 18, 2025

This marks a significant setback for the UK-based pharma company, which is aiming to regain approval of the therapy after it was pulled from the US market in 2022 due to concerns raised by late-stage trial data. The concern of ocular toxicity was first highlighted in a document published ahead of the ODAC meeting that took place on 17 July.

Communication

pharmaphorum

JULY 7, 2025

Skip to main content Monday 7 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Insurance Coverage and Processing

Beckers Hospital Review

AUGUST 12, 2025

“It creates additional work for all of us related to documentation, denial management and puts the patient in the middle,” Marjorie Bessel, MD, chief clinical officer at Phoenix-based Banner Health, told Becker’s. In recent years, Banner also has made a series of strategic moves to expand its outpatient footprint.

Inpatient

Beckers Hospital Review

AUGUST 1, 2025

Mr. Chan has led Iodine Software to the forefront of healthcare AI by developing predictive and intelligent tools that dramatically enhance clinical documentation and revenue cycle outcomes. She has assembled a high-performing team and developed educational initiatives that improve documentation quality and provider engagement.

Insurance Coverage and Processing

Beckers Hospital Review

AUGUST 8, 2025

Dr. Arline leads patient safety, quality, analytics, documentation and infection control at BayCare Health System, a 16-hospital network. She also implemented a readmission reduction program that improved the hospital’s CMS star rating from 2 to 4 stars between 2022 and 2024. Laura Arline, MD. A recognized leader statewide, Ms.

Hospitals

FDA Law Blog: Biosimilars

NOVEMBER 7, 2024

Sometimes, though, there is no clear precedent, and the product’s regulatory status falls into an undiscovered country. One less utilized method (and for good reason) to gain more certitude is the 513(g) Request for Information.

Documentation

pharmaphorum

AUGUST 6, 2025

Skip to main content Wednesday 6 August 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views (..)

Diabetes

Beckers Hospital Review

JULY 11, 2025

Mr. Calhoun has propelled Citizens Memorial Hospital into rural healthcare excellence since becoming CEO in 2022. Since November 2022, Mr. Farell has been responsible for overseeing the daily operations of St. Fast was appointed in July 2022 and leads St. Since taking the reins in 2022, Ms. Michael Calhoun. Clay Farell.

Hospitals

FDA Law Blog: Biosimilars

APRIL 14, 2025

When using ASCA, Summary Test Reports are included in a premarket submission using the format provided in the ASCA standards-specific guidance documents. The majority of device submissions that included ASCA Summary Test Reports were for basic safety and essential performance, with only 25% for biocompatibility.

Documentation

European Pharmaceutical Review

FEBRUARY 28, 2025

1 Following the current trend, there has been a significant rise in the number of documents mentioning both artificial intelligence (AI) and rare diseases. For documents published in 2014 this number was just six; in 2024 it was 157 ( Figure 2 ). 1 Figure 1 : Documents by year. 1 Figure 1 : Documents by year.

Documentation

STAT

JULY 18, 2025

market in 2022 after failing a late-stage study. In briefing documents released earlier this week, FDA staff highlighted their concerns about the ocular issues and suggested lower dosages could offer patients similar efficacy in treating multiple myeloma while lowering the risk of side effects.

Dosage

STAT

DECEMBER 28, 2022

Reflecting back on our favorite photographs from 2022, we are struck by how many portraits were in our selection. These images also document a pipeline program for Indigenous medical students, an incarcerated person fighting for better hepatitis C care, and a trailblazing Alzheimer’s researcher.

Documentation

STAT

FEBRUARY 27, 2023

Large hospital systems’ investments rebounded heavily in the final quarter of 2022, according to a new STAT analysis of financial filings. STAT analyzed the financial documents of 37 tax-exempt, not-for-profit health systems covering the last three months of 2022.

Hospitals

STAT

FEBRUARY 27, 2024

antitrust regulators into pharmaceutical industry middlemen has been stymied because the companies have failed to provide many of the documents that, in some cases, were requested as far back as June 2022. A much-anticipated inquiry by U.S.

Pharmaceutical Manufacturing

STAT

OCTOBER 20, 2023

The update included 171 new products that use artificial intelligence and machine learning, including 155 authorized since August of 2022. The agency’s data indicate that, after a lull during the Covid-19 pandemic, the number of authorized devices in 2023 is expected to increase by more than 30% over the prior year.

Documentation

Pharma Pathway

SEPTEMBER 17, 2022

Dasami Labs-Walk-In Drive for Quality Control/ Production/ AQA / Production Documentation/ Engineering On 18th Sept’ 2022. Walk-In Drive for Quality Control/ Production/ AQA / Production Documentation/ Engineering On 18th Sept’ 2022 On 18th Sept’ 2022 @ Dasami Labs. Date : 18th Sept’ 2022. Job Description.

Documentation

STAT

JANUARY 21, 2023

(AP) — Elizabeth Holmes is a flight risk and shouldn’t be allowed to stay out of prison while she appeals her 11-year prison sentence for defrauding investors, federal prosecutors said in court documents. Holmes had a one-way plane ticket to Mexico booked for Jan.

Documentation

Pharma Pathway

DECEMBER 14, 2022

Ltd- Walk-In Interview for Production & Documentation On 17th Dec’ 2022. Chemist in Production & Documentation @ Azico Biophore India Pvt. Department: Production & Documentation. Date : 17th Dec’ 2022. Ltd- Walk-In Interview for Production & Documentation On 17th Dec’ 2022.

Documentation

European Pharmaceutical Review

JANUARY 17, 2023

The Cell and Gene Therapy (CGT) Catapult has published its ‘ UK Advanced Therapy Medicinal Products (ATMP) Clinical Trials Report 2022 ’. The research observed this cell type took up 58 percent of UK ATMP clinical trials in 2022. . The number of Phase II/III trials increased from three trials in 2021 to seven trials in 2022.

Documentation

STAT

NOVEMBER 17, 2023

 The company’s final study plan was submitted to the FDA in 2022 and is expected to be completed  by 2030 , according to FDA briefing documents published earlier this week. They were approved under the FDA accelerated pathway in 2009 and 2014, respectively, for treating a rare form of blood cancer. The

Documentation

European Pharmaceutical Review

NOVEMBER 15, 2022

The International Generic and Biosimilar Medicines Association (IGBA)’s new whitepaper Embracing Science with Confidence: Adopting the Revised 2022 WHO Biosimilars Guideline suggests how the guideline provides great opportunity to revaluate how regulatory requirements can better advance biosimilar access. WHO Biosimilar Guideline updates.

Biosimilars

Pharmafile

JANUARY 20, 2023

India-based manufacturer Intas Pharmaceuticals has been issued a Form 483 by the FDA after three investigators found a “cascade of failure” in a site inspection carried out at their manufacturing facility in Pharmez Special Economic Zone (SEZ) between late November and early December 2022. read more

Documentation

Pharma Pathway

SEPTEMBER 24, 2022

Alkem Laboratories Ltd-Walk-In Interviews for Quality Control/ Quality Assurance/ Production On 1st Oct’ 2022. Date: 1st October’ 2022. Documents Required: Copy of your resume, Salary breakup/ Increment letter, Passport Size Photograph, Copy of Aadhaar & Pan Card. Job Description. Position : Officer/ Executive/ Sr.

Documentation